Skip to main content
ZJAMP Group Co., Ltd. logo

ZJAMP Group Co., Ltd. — Investor Relations & Filings

Ticker · 002758 ISIN · CNE100002029 LEI · 3003009OKT32LB5C0T64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,563 across all filing types
Latest filing 2020-10-30 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002758

About ZJAMP Group Co., Ltd.

https://www.znjtgf.com

ZJAMP Group Co., Ltd. specializes in the comprehensive distribution and supply chain management of agricultural production materials. The company’s core operations encompass the procurement, storage, and sale of essential inputs, including chemical fertilizers such as urea, potash, and compound fertilizers, as well as pesticides, seeds, and agricultural machinery. Beyond product distribution, the organization provides integrated technical services, modern logistics solutions, and agricultural consultancy to enhance crop yields and farming efficiency. By leveraging an extensive network of distribution centers and service stations, the group facilitates the stable supply of high-quality agricultural resources. Its business model focuses on bridging the gap between manufacturers and end-users through efficient resource allocation and value-added services.

Recent filings

Filing Released Lang Actions
关于发行股份购买资产暨关联交易事项实施的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Zhejiang Huatong Pharmaceutical Co., Ltd. regarding the progress of an asset purchase through share issuance and related party transactions. It references regulatory approval from the China Securities Regulatory Commission and details about the restructuring and board changes related to the transaction. The document is relatively short (1104 characters) and focuses on providing an update on the implementation progress of a major asset restructuring, including board elections and ongoing procedures. It does not contain full financial statements or detailed financial analysis, nor is it a transcript, audit report, or earnings release. It is not a full annual or interim report but rather a progress announcement related to a capital transaction and restructuring. Given the content and length, this fits best under Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including major asset acquisitions via share issuance.
2020-10-30 Chinese
2020年第三季度报告正文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2020 Third Quarter Report" of Zhejiang Huatong Pharmaceutical Co., Ltd. It contains detailed financial data including balance sheet items, profit and loss figures, cash flow statements, shareholder information, and notes on significant events during the quarter. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year (the third quarter) clearly indicates this is an Interim / Quarterly Report. The document length is 9070 characters, which is substantial and contains actual financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2020
2020-10-29 Chinese
第四届董事会第九次会议决议公告
Report Publication Announcement Classification · 95% confidence The document is a board meeting resolution announcement from Zhejiang Huatong Pharmaceutical Co., Ltd. It reports the approval of the company's 2020 third quarter report by the board of directors. The document states that the full third quarter report is available on the company's designated information disclosure media and provides links to it. The document itself does not contain the actual financial statements or substantive financial data but only announces the approval and availability of the report. The document length is short (744 characters), and it serves as an announcement rather than the report itself. According to the 'Menu vs Meal' rule, this should be classified as a Report Publication Announcement (RPA) rather than an Interim/Quarterly Report (IR).
2020-10-29 Chinese
2020年第三季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled "浙江华通医药股份有限公司 2020 年第三季度报告全文" which translates to "Zhejiang Huatong Pharmaceutical Co., Ltd. 2020 Third Quarter Report Full Text." It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the third quarter of 2020. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial data rather than just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2020
2020-10-29 Chinese
第四届监事会第八次会议决议公告
Report Publication Announcement Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Zhejiang Huatong Pharmaceutical Co., Ltd. regarding the approval of the company's 2020 third quarter report. It states that the full report is available on designated information disclosure media but does not contain the actual financial data or substantive analysis itself. The document is short (706 characters) and serves as an announcement of the report's approval and availability rather than the report itself. According to the 'Menu vs Meal' rule, this type of document should be classified as a Report Publication Announcement (RPA) rather than an Interim/Quarterly Report (IR).
2020-10-29 Chinese
独立董事关于公司第四届董事会第八次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion statement from independent directors regarding board matters such as management changes and use of idle funds. It references compliance with regulatory rules and company bylaws but does not contain financial statements or detailed financial results. The document is short (1115 characters) and focuses on board and management decisions rather than financial reporting. Therefore, it fits best under Board/Management Information (MANG) as it announces changes in senior management and related opinions from the board.
2020-10-26 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.